Koch C - Search Results

1

Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success?--A 30-year cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection.

Johansen HK, Nørregaard L, Gøtzsche PC, Pressler T, Koch C, Høiby N. Johansen HK, et al. Among authors: koch c. Pediatr Pulmonol. 2004 May;37(5):427-32. doi: 10.1002/ppul.10457. Pediatr Pulmonol. 2004. PMID: 15095326

2

Dornase alfa in the treatment of cystic fibrosis in Europe: a report from the Epidemiologic Registry of Cystic Fibrosis.

Hodson ME, McKenzie S, Harms HK, Koch C, Mastella G, Navarro J, Strandvik B; Investigators of the Epidemiologic Registry of Cystic Fibrosis. Hodson ME, et al. Among authors: koch c. Pediatr Pulmonol. 2003 Nov;36(5):427-32. doi: 10.1002/ppul.10348. Pediatr Pulmonol. 2003. PMID: 14520726

3

Cushing's syndrome due to pharmacological interaction in a cystic fibrosis patient.

Main KM, Skov M, Sillesen IB, Dige-Petersen H, Müller J, Koch C, Lanng S. Main KM, et al. Among authors: koch c. Acta Paediatr. 2002;91(9):1008-11. doi: 10.1080/080352502760272759. Acta Paediatr. 2002. PMID: 12412882

4

[Glucose tolerance in patients with cystic fibrosis].

Thorsteinsson SL, Hansen A, Thorsteinsson B, Nerup J, Koch C. Thorsteinsson SL, et al. Among authors: koch c. Ugeskr Laeger. 1996 Oct 28;158(44):6269-73. Ugeskr Laeger. 1996. PMID: 8966811 Danish.

5

[Reduced concentration of insulin-like growth factor I in patients with cystic fibrosis].

Laursen EM, Juul A, Thorsteinsson SL, Høiby N, Koch C, Müller JR, Skakkebaek NE. Laursen EM, et al. Among authors: koch c. Ugeskr Laeger. 1996 Sep 16;158(38):5300-2. Ugeskr Laeger. 1996. PMID: 8966779 Danish.

6

Specific IgG2 antibodies to Pseudomonas aeruginosa lipid A and lipopolysaccharide are early markers of chronic infection in patients with cystic fibrosis.

Kronborg G, Pressler T, Fomsgaard A, Koch C, Høiby N. Kronborg G, et al. Among authors: koch c. Infection. 1993 Sep-Oct;21(5):297-302. doi: 10.1007/BF01712448. Infection. 1993. PMID: 8300245

7

Proinsulin, insulin, and C-peptide in cystic fibrosis after an oral glucose tolerance test.

Hartling SG, Garne S, Binder C, Heilmann C, Petersen W, Petersen KE, Koch C. Hartling SG, et al. Among authors: koch c. Diabetes Res. 1988 Apr;7(4):165-9. Diabetes Res. 1988. PMID: 3042255

8

Serum antibodies to Aspergillus fumigatus catalase in patients with cystic fibrosis.

Schønheyder H, Jensen T, Laessøe IH, Høiby N, Koch C. Schønheyder H, et al. Among authors: koch c. Eur J Clin Microbiol Infect Dis. 1988 Feb;7(1):40-4. doi: 10.1007/BF01962169. Eur J Clin Microbiol Infect Dis. 1988. PMID: 3132374

9

Correlation between specific IgG subclass antibodies to Pseudomonas aeruginosa and opsonic activity in serum from patients with cystic fibrosis.

Pressler T, Jensen ET, Espersen F, Pedersen SS, Høiby N, Koch C. Pressler T, et al. Among authors: koch c. Pediatr Pulmonol. 1994 Jan;17(1):31-40. doi: 10.1002/ppul.1950170107. Pediatr Pulmonol. 1994. PMID: 8108174

10

[Prevention of cystic fibrosis?].

Koch C. Koch C. Ugeskr Laeger. 1996 Aug 12;158(33):4622. Ugeskr Laeger. 1996. PMID: 8760516 Danish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results